Teladoc Health, Inc. (NYSE:TDOC) to Post FY2025 Earnings of ($0.82) Per Share, Oppenheimer Forecasts

Teladoc Health, Inc. (NYSE:TDOC – Get Rating) – Equities research analysts at Oppenheimer issued their FY2025 earnings per share estimates for Teladoc Health in a research note issued to investors on Thursday, January 19th. Oppenheimer analyst M. Wiederhorn forecasts that the health services provider will post earnings of ($0.82) per share for the year. Oppenheimer currently has a “Outperform” rating and a $37.00 target price on the stock. The consensus estimate for Teladoc Health’s current full-year earnings is ($1.40) per share.

Teladoc Health (NYSE:TDOC – Get Rating) last released its earnings results on Wednesday, October 26th. The health services provider reported ($0.45) EPS for the quarter, topping the consensus estimate of ($0.59) by $0.14. The business had revenue of $611.40 million for the quarter, compared to the consensus estimate of $609.45 million. Teladoc Health had a negative return on equity of 2.47% and a negative net margin of 424.40%.

A number of other brokerages have also commented on TDOC. DA Davidson dropped their price target on Teladoc Health from $45.00 to $40.00 and set a “buy” rating for the company in a research note on Tuesday, October 25th. Deutsche Bank Aktiengesellschaft reduced their price target on Teladoc Health from $34.00 to $31.00 and set a “hold” rating on the stock in a report on Tuesday, September 27th. Truist Financial reduced their price objective on Teladoc Health from $35.00 to $29.00 and set a “hold” rating on the stock in a report on Friday, October 21st. Barclays cut their price target on Teladoc Health from $32.00 to $28.00 and set an “equal weight” rating on the stock in a report on Wednesday. Finally, Royal Bank of Canada lowered their price objective on Teladoc Health from $53.00 to $35.00 in a research report on Wednesday, September 28th. One equities research analyst has rated the stock with a sell rating, twenty-two have issued a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $47.79.

Teladoc Health Stock Performance

Shares of TDOC opened at $26.18 on Friday. The company has a quick ratio of 2.99, a current ratio of 3.13 and a debt-to-equity ratio of 0.25. The business has a 50-day simple moving average of $26.45 and a two-hundred day simple moving average of $30.30. The stock has a market cap of $4.24 billion, a price-to-earnings ratio of -0.43 and a beta of 0.98. Teladoc Health has a 52 week low of $21.60 and a 52 week high of $80.83.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Quantum Private Wealth LLC lifted its stake in shares of Teladoc Health by 15.2% in the 4th quarter. Quantum Private Wealth LLC now owns 9,844 shares of the health services provider’s stock worth $233,000 after acquiring an additional 1,300 shares during the period. Householder Group Estate & Retirement Specialist LLC lifted its stake in shares of Teladoc Health by 17.1% in the 4th quarter. Householder Group Estate & Retirement Specialist LLC now owns 3,062 shares of the health services provider’s stock worth $72,000 after acquiring an additional 448 shares during the period. Maryland State Retirement & Pension System acquired a new stake in shares of Teladoc Health in the 4th quarter worth approximately $272,000. Exchange Traded Concepts LLC lifted its stake in shares of Teladoc Health by 7.4% in the 4th quarter. Exchange Traded Concepts LLC now owns 32,530 shares of the health services provider’s stock worth $769,000 after acquiring an additional 2,231 shares during the period. Finally, Ronald Blue Trust Inc. lifted its stake in shares of Teladoc Health by 814.5% in the 4th quarter. Ronald Blue Trust Inc. now owns 2,908 shares of the health services provider’s stock worth $74,000 after acquiring an additional 2,590 shares during the period. 84.14% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Teladoc Health

In related news, SVP Daniel Trencher sold 1,000 shares of the business’s stock in a transaction dated Tuesday, January 17th. The shares were sold at an average price of $26.80, for a total transaction of $26,800.00. Following the completion of the sale, the senior vice president now owns 21,408 shares of the company’s stock, valued at approximately $573,734.40. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other Teladoc Health news, insider Arnnon Geshuri sold 2,398 shares of the business’s stock in a transaction dated Monday, November 28th. The shares were sold at an average price of $27.35, for a total transaction of $65,585.30. Following the completion of the transaction, the insider now directly owns 74,317 shares of the company’s stock, valued at approximately $2,032,569.95. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Daniel Trencher sold 1,000 shares of the business’s stock in a transaction dated Tuesday, January 17th. The shares were sold at an average price of $26.80, for a total transaction of $26,800.00. Following the transaction, the senior vice president now directly owns 21,408 shares of the company’s stock, valued at $573,734.40. The disclosure for this sale can be found here. Insiders sold a total of 3,925 shares of company stock valued at $107,958 in the last quarter. Insiders own 1.55% of the company’s stock.

Teladoc Health Company Profile

(Get Rating)

Teladoc Health, Inc provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions.